|
The new medical reform policies led directly to pharmaceutical distribution market shrinking cake. Out the weak, the strong stronger, pharmaceutical distribution industry, "Matthew Effect" will appear gradually. On target, as at the end of March this year, a 30% to the country provinces (autonomous regions and municipalities), the implementation of primary health care institutions basic drugs, and the implementation of public procurement, uniform distribution and zero slip sales, pharmaceutical circulation cake suddenly shrink, distribution companies will go from here? Shrinking cake For the entire pharmaceutical industry, the new medical reform is a great good policy, but specific to the pharmaceutical distribution business, the situation different?? New medical reform policies led directly to pharmaceutical distribution market pie has shrunk. "Pharmaceutical distribution business integration and integration of the entire pharmaceutical industry in medicine difference is the integration of distribution companies will significantly reduce the circulation, and this is precisely the part of pharmaceutical distribution companies are the major source of profits. Therefore, in the pharmaceutical distribution companies integrated the same time, their cake was cut. "investment consultant in the pharmaceutical industry where researchers Guo Li to the" Sankei Shimbun in China, "said journalist. 2009, the brewing three years, the official introduction of new medical reform program. Circulation in medicine, new medical reform "views" clear that the government-run medical institutions to use essential medicines agency designated by the provincial people's government open tender procurement, tender selected by the uniform distribution distribution business. "Opinions" also pointed out that the country should be at the end of a 30% provincial (autonomous regions and municipalities) the completion of this goal, the goal of completion will be delayed until the completion of the end of March this year. Medicine refers to a broad distribution of patients from pharmaceutical companies to all intermediate links. Traditional pattern, the pharmaceutical manufacturer to the final were from the general experience of multi-agent, in this structure, the layers of the fare increase is the prevailing "rules of the game," which is the survival of many small and medium circulation enterprises, the foundation. Can be seen from the successful enterprises of new medical reform provisions of uniform distribution of many distribution companies directly off the "rice bowl." Matthew "Eliminate the weak, the strong stronger, pharmaceutical distribution industry, the 'Matthew effect' will gradually appear." Guo Fan Li pointed out that for small and medium enterprises in the pharmaceutical distribution industry, the price they pay may be merged or disappeared ; the pharmaceutical distribution industry for leading companies such as Sinopharm, new drugs and Kyushu pass it on, then they can get more profits. At present, holders of more than 8,000 pharmaceutical distribution companies (excluding subsidiaries), most of them small-scale; 2007 sales reached 50 million yuan more than 500 Chinese business enterprises only; industry three power Pharmaceutical Group, the drug shares and the scale of Kyushu through group sales were Chaobai Yi, three accounted for 20% share of the national circulation. "To survive, SMEs must fill loopholes large enterprises, competitive differentiation, because the large group and then a large network can not achieve complete coverage, such as some small and remote place." Consulting pharmaceutical analyst Pong Morning side to the "China Sankei Shimbun" reporter pointed out that small and medium circulation enterprises is very bad, it faced pressure to identify the survival strategies. The current pharmaceutical market merger and reorganization among the various enterprise groups turbulent, some large pharmaceutical giant basic seating has been scheduled, the market has been divided similarly, the SMEs must be another idea to avoid direct competition. But for large enterprise groups is a great good news that contrary. Recently, Sinopharm, North medicines frequent moves, a series of mergers, there is plenty of action most of the design integration of circulation, are competing to Happy Valley enclosure, hoping to seize the initiative in the network layout. To the Chinese medicine sector boss Sinopharm example, Sinopharm covered more than 7,800 hospitals, more than 3,000 distributors. The e-commerce company in China offers quality products such as Polyurethane Sealants Manufacturer , Polyurethane Sealants Manufacturer, and more. For more , please visit Aerosol Spray Paints today!
Related Articles -
Polyurethane Sealants Manufacturer, Polyurethane Sealants Manufacturer,
|
